title: Tertiary prevention of cervical cancer.
abstract: Human pappilomavirus (HPV) has been recognized as the most common sexually transmitted disease in the world and over 100 different HPV types have been identified. Persistent HPV infection has been closely linked to the development of invasive cervical cancer. Although surgical and ablative therapies have been the mainstay of treatment, vaccination against the main oncogenic type of HPV is a reasonable preventive strategy for HPV-induced cervical cancer.
authors.affiliation: *Department of Obstetrics and Gynecology †Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: Laura M
authors.initials: LM
authors.lastname: Divine
authors.forename: Warner K
authors.initials: WK
authors.lastname: Huh
mesh_terms: D005260:Female; D006801:Humans; D007167:Immunotherapy; D009367:Neoplasm Staging; D030361:Papillomavirus Infections / Q000150:complications / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D010789:Phototherapy; D017410:Practice Guidelines as Topic; D055512:Tertiary Prevention; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000628:therapy* / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000276:immunology / Q000517:prevention & control / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines